European Archives - Page 859 of 1022 - European Medical Journal

EMJ

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

This symposium took place on 29th September 2016 as a part of the European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria…

EAACI Sheds Light on Recent Developments in Severe Asthma

United Kingdom, November 17, 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) hosts today in Manchester the 3rd International…

Introducing EMJ Dermatology 4.1

United Kingdom, November 15, 2016: Hello and welcome to this year’s EMJ Dermatology eJournal, updating the field with cutting-edge developments within…

EMJ

Epstein-Barr Virus: Cholestasis, Hepatitis, Or Both?

Epstein-Barr Virus (EBV), or more commonly known as the ‘kissing disease’ is seemingly unavoidable within the adolescent and teenage community.

Useful Photoprotection in Dermatological Practice

The main objectives of this symposium were to explore the effect of light on individuals with hyperpigmentation disorders and acne, present the latest…

Will Biosimilars Change the Treatment Paradigm in Psoriasis?

Prof Augustin opened the meeting and reviewed the use of systemic treatments recommended for moderate-to-severe psoriasis. Data indicating a lack of…

Quality of Care: The Challenges, The Solutions

Psoriatic arthritis (PsA) and hidradenitis suppurativa (HS) are both immune-mediated diseases with common cellular and cytokine pathways involved in…

Value in Psoriasis Care: From Patients to Payers

The symposium explored new approaches to optimising the value of psoriasis management from the perspective of physicians, patients, and healthcare…

Editor’s Pick: The Role of Toll-Like Receptors and Antimicrobial Peptides in the Pathogenesis of Acne Vulgaris

Acne vulgaris (AV) is a chronic inflammatory disease of the pilosebaceous unit. AV has a multifactorial pathogenesis with specific roles played by the…

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children: A Literature Review of Current Treatments

Stevens-Johnson syndrome and toxic epidermal necrolysis are among the most concerning drug reactions affecting adults and children. Although the overall…